Beijing Foyou Pharma CO.,LTD (SHA:601089)
China · Delayed Price · Currency is CNY 15.02
-0.30 (-1.96%)
At close: Nov 13, 2026
SHA:601089 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,029 | 11,232 | 7,488 | 8,275 | 7,358 | - | |
Market Cap Growth | -32.49% | 50.00% | -9.51% | 12.46% | - | - |
Enterprise Value | 4,915 | 9,207 | 5,284 | 5,917 | 5,133 | - |
Last Close Price | 15.02 | 23.35 | 15.10 | 15.71 | 13.68 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.64 | 23.93 | 15.32 | 16.93 | 16.77 | - |
PS Ratio | 1.95 | 3.21 | 2.17 | 2.48 | 2.27 | - |
PB Ratio | 1.84 | 2.96 | 2.11 | 2.38 | 2.32 | - |
P/TBV Ratio | 1.91 | 3.09 | 2.20 | 2.49 | 2.43 | - |
P/FCF Ratio | 23.20 | - | 25.02 | 43.59 | 14.03 | - |
P/OCF Ratio | 16.63 | 31.13 | 10.84 | 14.89 | 11.15 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.36 | 2.63 | 1.53 | 1.77 | 1.58 | - |
EV/EBITDA Ratio | 9.43 | 15.22 | 9.49 | 10.54 | 10.27 | - |
EV/EBIT Ratio | 13.21 | 18.68 | 11.19 | 12.29 | 11.86 | - |
EV/FCF Ratio | 16.22 | - | 17.66 | 31.17 | 9.79 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 | 0.11 |
Debt / EBITDA Ratio | 0.02 | 0.04 | 0.13 | 0.21 | 0.24 | 0.33 |
Debt / FCF Ratio | 0.04 | - | 0.25 | 0.66 | 0.23 | 0.41 |
Net Debt / Equity Ratio | -0.56 | -0.54 | -0.65 | -0.69 | -0.76 | -0.33 |
Net Debt / EBITDA Ratio | -4.22 | -3.37 | -4.13 | -4.29 | -4.84 | -0.96 |
Net Debt / FCF Ratio | -7.03 | 55.74 | -7.68 | -12.68 | -4.61 | -1.18 |
Asset Turnover | 0.74 | 0.72 | 0.74 | 0.75 | 1.00 | 1.47 |
Inventory Turnover | 3.37 | 3.22 | 3.50 | 3.49 | 3.14 | 2.91 |
Quick Ratio | 2.55 | 2.46 | 2.38 | 2.98 | 2.86 | 1.07 |
Current Ratio | 3.03 | 2.90 | 2.69 | 3.33 | 3.20 | 1.48 |
Return on Equity (ROE) | 9.82% | 12.83% | 13.99% | 14.79% | 20.01% | 28.42% |
Return on Assets (ROA) | 4.78% | 6.33% | 6.31% | 6.79% | 8.36% | 11.50% |
Return on Invested Capital (ROIC) | 20.06% | 29.46% | 36.97% | 47.17% | 49.60% | 38.55% |
Return on Capital Employed (ROCE) | 9.50% | 12.70% | 13.00% | 13.60% | 13.20% | 27.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.36% | 4.18% | 6.53% | 5.91% | 5.96% | - |
FCF Yield | 4.31% | -0.33% | 4.00% | 2.29% | 7.13% | - |
Dividend Yield | 3.33% | 2.08% | 3.13% | 2.90% | 2.61% | - |
Payout Ratio | 63.61% | 49.91% | 48.41% | 39.81% | 25.34% | 36.32% |
Buyback Yield / Dilution | 4.29% | 0.11% | 1.94% | -13.55% | -16.75% | -0.44% |
Total Shareholder Return | 7.62% | 2.19% | 5.07% | -10.65% | -14.14% | -0.44% |